Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028
... report on the duchenne muscular dystrophy (DMD) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Japan Cancer Supportive Care Market, By Therapeutics Class (G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Anti-emetics, Bisphosphonates, Opioids, NSAIDs, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
... at USD 365.25 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 2.25% through 2030. Vitamin supplements are designed to enhance the regular diet by providing ... Read More
-
Drug Discovery Services Global Market Opportunities And Strategies To 2033
... Biotechnology Companies; Academic Institutes4) By Drug Type: Biologics Drug; Small Molecule DrugCovering: Charles River Laboratories International, Inc.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Evotec SE; Eurofins Scientific SE Drug Discovery Services Global ... Read More
-
Next Generation Sequencing Market Analysis and Forecast to 2033: By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), PRODUCT (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), WORKFLOW (NGS Library Preparation Kits, Semi-automated Library Preparation, Automated Library Preparation, Sequenc
... Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals ... Read More
-
Global Insomnia Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Drug Discovery Technologies
... compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies’ current and future market potential and gives a detailed analysis of the ... Read More
-
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2024(Status and Outlook)
... disease that causes nerve cells to gradually break down and die. The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half ... Read More
-
Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By Therapeutics, By Region, By Country: Market Insights and Forecast (2020-2030)
... a research report titled “Global Biliary Tract Cancer Market (2024 Edition)” which provides an analysis of the Global Biliary Tract Cancer industry in terms of market segmentation By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile ... Read More
-
Chronic Venous Insufficiency - Market Insight, Epidemiology And Market Forecast - 2034
... estimates, in 2023, there were approximately 470 million total prevalent cases of CVD in the 7MM. These cases are projected to rise during the study period. In the US, there were 52 million total diagnosed ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034
... market size of FECD in the 7MM is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that among the Total Diagnosed Prevalent Cases of Fuchs Endothelial Corneal Dystrophy (FECD) in ... Read More
-
Systemic Sclerosis Market Insight, Epidemiology And Market Forecast - 2034
... by the US. Among EU4 and the UK, Italy accounted for the largest market size, whereas Spain accounted for the smallest market size in 2023. In the 7MM, the US accounted for the highest number ... Read More
-
Mydriasis - Market Insight, Epidemiology And Market Forecast - 2034
... This growth will be driven primarily by the increase in age-related eye conditions such as cataracts, glaucoma, and macular degeneration, leading to more eye exams and surgeries. The increasing prevalence of chronic conditions such as ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
... growth is attributed to the rising number of incident cases, the launch of emerging therapies, and increased awareness of ACC. DelveInsight’s analyst forecasts that around 27% of all Adrenocortical Carcinoma (ACC) cases in the 7MM ... Read More
-
Schizophrenia Therapeutics
... at a CAGR of 4.2% over the analysis period 2023-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$7.7 Billion by the ... Read More
-
Bovine Respiratory Disease Treatment
... reach US$3.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.4 ... Read More
-
Microbiome Therapeutics
... at a CAGR of 56.9% over the analysis period 2023-2030. C. Difficile Infection, one of the segments analyzed in the report, is expected to record a 53.2% CAGR and reach US$7.3 Billion by the end ... Read More
-
Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast–2034
... nearly USD 12 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). Analysts at DelveInsight project that approximately 54% of the Total Diagnosed Prevalent Cases of Molybdenum Cofactor Deficiency ... Read More
-
Vitiligo Therapeutics
... at a CAGR of 4.0% over the analysis period 2023-2030. Topical Therapeutics, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Postherpetic Neuralgia - Market Insight, Epidemiology And Market Forecast - 2034
... neuralgia occurs in a subset of the population suffering from an episode of acute herpes zoster. The incidence of herpes zoster increases with age, with most cases occurring in patients over 50. FDA-approved options encompass ... Read More
-
Prader-Willi Syndrome Market Insight, Epidemiology And Market Forecast - 2034
... characterized by a range of challenging symptoms, including hyperphagia (excessive hunger), obesity, and behavioral issues. PWS is often misdiagnosed in neonates because of its nonspecific clinical manifestations. Definitive molecular genetic testing should be readily accessible ... Read More
-
Global Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By Therapies, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Azoth Analytics has released a research report titled “Global Ophthalmic Disease Therapeutics Market (2024 Edition)” which provides a Age-related macular degeneration analysis of the Global Ophthalmic Disease Therapeutics industry in terms of market segmentation By ... Read More
-
Idiopathic Membranous Nephropathy Market Insight, Epidemiology And Market Forecast - 2032
... urine (nephrotic syndrome) and is primarily an autoimmune condition. There is currently no specific approved drugs for IMN, and management typically focuses on supportive care. The market is anticipated to witness a substantial positive shift ... Read More
-
Peripheral Neuropathic Pain - Market Insight, Epidemiology And Market Forecast - 2034
... or tumor invasion. Peripheral neuropathy has various causes, with diabetic peripheral neuropathy (DPN) being the most common subtype in the 7MM. Lumbosacral radiculopathy (LSR) is another significant contributor to peripheral neuropathy, followed by post-operative PNP, ... Read More
-
Systemic Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2034
... relapsing and remitting course. Systemic lupus erythematosus mostly affects women. Approximately, 90% of women seem to be affected by the prevalence of systemic lupus erythematosus. Among 7MM, the US accounted for the highest number of ... Read More
-
Neurotrophic Keratitis Market Insight, Epidemiology And Market Forecast - 2034
... is further expected to increase by 2034. In 2023, the prevalence of Neurotrophic keratitis was highest in the US among the 7MM, accounting for nearly 66 thousand cases which is further expected to increase by ... Read More
Research Assistance
